Switch to:
Allergan Inc (NYSE:AGN)
Piotroski F-Score
8 (As of Today)

Good Sign:

Piotroski F-Score of 8 is 8, indicating very healthy situation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Allergan Inc has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.

AGN' s 10-Year Piotroski F-Score Range
Min: 3   Max: 9
Current: 8

3
9

During the past 13 years, the highest Piotroski F-Score of Allergan Inc was 9. The lowest was 3. And the median was 6.


Definition

How is the Piotroski F-Score calculated?

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Mar14) TTM:Last Year (Mar13) TTM:
Net Income was 257.3 + 312.9 + 299.8 + 359.9 = $1,230 Mil.
Cash Flow from Operations was 165.8 + 515.3 + 579 + 481.5 = $1,742 Mil.
Revenue was 1646.1 + 1684.4 + 1558.7 + 1597.7 = $6,487 Mil.
Gross Profit was 1441.6 + 1479.8 + 1366.5 + 1398.6 = $5,687 Mil.
Total Assets at the begining of this year (Mar13) was $9,251 Mil.
Total Assets was $10,720 Mil.
Long-Term Debt was $2,095 Mil.
Total Current Assets was $5,459 Mil.
Total Current Liabilities was $1,248 Mil.
Net Income was 12.5 + 324.2 + 249.4 + 295.4 = $882 Mil.

Revenue was 1459.6 + 1472.1 + 1376.5 + 1450.1 = $5,758 Mil.
Gross Profit was 1259.7 + 1289.1 + 1193.6 + 1254.8 = $4,997 Mil.
Total Assets at the begining of last year (Mar12) was $8,684 Mil.
Total Assets was $9,251 Mil.
Long-Term Debt was $2,108 Mil.
Total Current Assets was $4,070 Mil.
Total Current Liabilities was $1,062 Mil.

Profitability

Q1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Allergan Inc's current net income was 1,230. ==> Positive ==> Score 1.

Q2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by total assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Allergan Inc's current cash flow from operations was 1,742. ==> Positive ==> Score 1.

Q3. Change in Return on Assets

Compare this year’s return on assets (1) to last year’s return on assets.

Score 1 if it’s higher, 0 if it’s lower.

ROA (This Year)=Net Income/Total Assets at the beginning of this year (Mar13)
=1229.9/9250.5
=0.13295498

ROA (Last Year)=Net Income/Total Assets at the beginning of last year (Mar12)
=881.5/8684.2
=0.10150618

Allergan Inc's return on assets of this year was 0.13295498. Allergan Inc's return on assets of last year was 0.10150618. ==> This year is higher. ==> Score 1.

Q4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA =< ROA.

Allergan Inc's current net income was 1,230. Allergan Inc's current cash flow from operations was 1,742. ==> 1,742 > 1,230 ==> CFROA > ROA ==> Score 1.

Funding

Q5. Change in Gearing or Leverage

Compare this year’s gearing (long-term debt divided by average total assets) to last year’s gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year)=Long-Term Debt/Total Assets
=2095.1/10720.2
=0.19543479

Gearing (Last Year)=Long-Term Debt/Total Assets
=2107.7/9250.5
=0.22784714

Allergan Inc's gearing of this year was 0.19543479. Allergan Inc's gearing of last year was 0.22784714. ==> This year is lower or equal to last year. ==> Score 1.

Q6. Change in Working Capital (Liquidity)

Compare this year’s current ratio (current assets divided by current liabilities) to last year’s current ratio.

Score 1 if this year'’s current ratio is higher, 0 if it’s lower

Current Ratio (This Year)=Total Current Assets/Total Current Liabilities
=5458.7/1248.1
=4.37360788

Current Ratio (Last Year)=Total Current Assets/Total Current Liabilities
=4069.5/1061.5
=3.83372586

Allergan Inc's current ratio of this year was 4.37360788. Allergan Inc's current ratio of last year was 3.83372586. ==> This year's current ratio is higher. ==> Score 1.

Q7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Allergan Inc's number of shares in issue this year was 297.9. Allergan Inc's number of shares in issue last year was 297.7. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Q8. Change in Gross Margin

Compare this year’s gross margin (gross profit divided by sales) to last year’s.

Score 1 if this year’s gross margin is higher, 0 if it’s lower.

Gross Margin (This Year)=Gross Profit/Revenue
=5686.5/6486.9
=0.87661287

Gross Margin (Last Year)=Gross Profit/Revenue
=4997.2/5758.3
=0.86782557

Allergan Inc's gross margin of this year was 0.87661287. Allergan Inc's gross margin of last year was 0.86782557. ==> This year's gross margin is higher. ==> Score 1.

Q9. Change in asset turnover

Compare this year’s asset turnover (total sales divided by total assets at the beginning of the year) to last year’s asset turnover ratio.

Score 1 if this year’s asset turnover ratio is higher, 0 if it’s lower

Asset Turnover (This Year)=Revenue/Total Assets at the beginning of this year (Mar13)
=6486.9/9250.5
=0.70124858

Asset Turnover (Last Year)=Revenue/Total Assets at the beginning of last year (Mar12)
=5758.3/8684.2
=0.66307777

Allergan Inc's asset turnover of this year was 0.70124858. Allergan Inc's asset turnover of last year was 0.66307777. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score=Q1+Q2+Q3+Q4+Q5+Q6+Q7+Q8+Q9
=1+1+1+1+1+1+0+1+1
=8

Good or high score = 8 or 9

Bad or low score = 0 or 1

Allergan Inc has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.


Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Related Terms

Net Income, Cash Flow from Operations, Revenue, Gross Profit, Total Assets, Long-Term Debt, Total Current Assets, Total Current Liabilities


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Allergan Inc Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Q1 1101111111
Q2 1111111111
Q3 1001010110
Q4 1111111111
Q5 1101111110
Q6 1010110110
Q7 0000110011
Q8 1101011111
Q9 1010000011
F-score 8546685796

Allergan Inc Quarterly Data

Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14
Q1 1111111111
Q2 1111111111
Q3 1111100001
Q4 1111111111
Q5 1111100001
Q6 1111100001
Q7 1111111110
Q8 1111111111
Q9 0011110111
F-score 8899965668
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide